Word of Merck’s Claim of Fifth Fosamax Bisphosphonate Court Victory Disheartens Rottenstein Law Group
(New York, NY, April 24, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the bisphosphonate drug Fosamax, is disheartened to learn that Merck, the drug’s manufacturer, is claiming victory in a fifth lawsuit.
In a press release dated April 18, Merck & Co., Inc. announced that “a state court jury in New Jersey found in [Merck’s] favor in the Sessner v. Merck case, rejecting the claims of a woman who blamed her jaw-related problems on her FOSAMAX use.”
“We believe the evidence showed the company acted properly, and that [Fosamax]did not cause the plaintiff’s dental and jaw problems,” said outside counsel for Merck, according to the press release.
Judge Carol E. Higbee of the Superior Court for Atlantic County, N.J., presided over the trial (Docket No. ATL-L-3394-11-MT), the sixth Fosamax bisphosphonate case to go to trial. Merck has won five of the six trials. Four trials were conducted as part of the federal multidistrict litigation proceedings before Judge John F. Keenan in the U.S. District Court for the Southern District of New York.
Despite being the most popular osteoporosis treatment on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition that causes the jawbone to literally die because of a lack of blood supply. More recently, there has been a link between Fosamax and low-impact femur fractures experienced from standing height or less. Evidence is mounting that Fosamax and other bisphosphonate drugs prescribed to treat osteoporosis cause a dramatic increase in the risk of this kind of rare fracture to the thigh bone.
The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.
- Contact Information
- Nava Brahe
- PR Manager
- The Rottenstein Law Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.